KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) Cash & Equivalents (2009 - 2026)

Abbott Laboratories recorded quarterly Cash & Equivalents of $6.8 billion in Q1 2026, down 20.17% quarter-over-quarter from $8.5 billion in Q4 2025, and up 4.15% year-over-year from $6.5 billion in Q1 2025.

Abbott Laboratories' Cash & Equivalents history runs 18 years deep, the most recent figure standing at $6.8 billion for Q1 2026.

  • In Q1 2026, Cash & Equivalents rose 4.15% year-over-year to $6.8 billion; the TTM figure through Mar 2026 stood at $6.8 billion (up 4.15% YoY), while the FY2025 annual figure was $8.5 billion, up 11.9% from the prior year.
  • Cash & Equivalents came in at $6.8 billion for Q1 2026 at Abbott Laboratories, down from $8.5 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $9.9 billion in Q4 2022 to a low of $6.3 billion in Q1 2024.
  • A 5-year average of $7.7 billion and a median of $7.6 billion in 2024 frame the typical range for Cash & Equivalents.
  • Across the five-year window, Cash & Equivalents gained 19.36% in 2023 and slumped 31.4% in 2024, its largest moves.
  • Abbott Laboratories' Cash & Equivalents stood at $9.9 billion in 2022, then slumped by 30.22% to $6.9 billion in 2023, then grew by 10.44% to $7.6 billion in 2024, then gained by 11.9% to $8.5 billion in 2025, then retreated by 20.17% to $6.8 billion in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods registered $6.8 billion, $8.5 billion, and $7.5 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 6.80 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 2.88 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.45 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 2.45 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 3.03 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 1.12 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 2.29 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 439.60 Mn
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 424.20 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 6.80 Bn
Dec 31, 2025 8.52 Bn
Sep 30, 2025 7.51 Bn
Jun 30, 2025 6.95 Bn
Mar 31, 2025 6.53 Bn
Dec 31, 2024 7.62 Bn
Sep 30, 2024 7.56 Bn
Jun 30, 2024 6.99 Bn
Mar 31, 2024 6.28 Bn
Dec 31, 2023 6.90 Bn
Sep 30, 2023 6.71 Bn
Jun 30, 2023 7.84 Bn
Mar 31, 2023 9.16 Bn
Dec 31, 2022 9.88 Bn
Sep 30, 2022 9.59 Bn
Jun 30, 2022 8.94 Bn
Mar 31, 2022 7.68 Bn
Dec 31, 2021 9.80 Bn
Sep 30, 2021 9.30 Bn
Jun 30, 2021 8.66 Bn
Mar 31, 2021 8.05 Bn
Dec 31, 2020 6.84 Bn
Sep 30, 2020 4.48 Bn
Jun 30, 2020 4.76 Bn
Mar 31, 2020 3.38 Bn
Dec 31, 2019 3.86 Bn
Sep 30, 2019 4.09 Bn
Jun 30, 2019 3.14 Bn
Mar 31, 2019 3.02 Bn
Dec 31, 2018 4.98 Bn
Sep 30, 2018 7.37 Bn
Jun 30, 2018 3.07 Bn
Mar 31, 2018 3.86 Bn
Dec 31, 2017 10.49 Bn
Sep 30, 2017 11.01 Bn
Jun 30, 2017 9.68 Bn
Mar 31, 2017 8.71 Bn
Dec 31, 2016 21.72 Bn
Sep 30, 2016 2.50 Bn
Jun 30, 2016 2.58 Bn
Mar 31, 2016 3.33 Bn
Dec 31, 2015 5.00 Bn
Sep 30, 2015 3.13 Bn
Jun 30, 2015 4.05 Bn
Mar 31, 2015 3.23 Bn
Dec 31, 2014 4.06 Bn
Sep 30, 2014 3.61 Bn
Jun 30, 2014 3.57 Bn
Mar 31, 2014 2.06 Bn
Dec 31, 2013 3.48 Bn
Sep 30, 2013 2.88 Bn
Jun 30, 2013 5.57 Bn
Mar 31, 2013 4.37 Bn
Dec 31, 2012 10.80 Bn
Sep 30, 2012 8.00 Bn
Jun 30, 2012 7.05 Bn
Mar 31, 2012 4.35 Bn
Dec 31, 2011 6.81 Bn
Sep 30, 2011 5.05 Bn
Jun 30, 2011 4.08 Bn
Mar 31, 2011 2.74 Bn
Dec 31, 2010 3.65 Bn
Sep 30, 2010 3.82 Bn
Jun 30, 2010 4.32 Bn
Mar 31, 2010 1.87 Bn
Dec 31, 2009 8.81 Bn
Sep 30, 2009 4.88 Bn
Jun 30, 2009 4.20 Bn